European collaboration on relative effectiveness assessments: What is needed to be successful?

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The objective of this study is to identify the possible barriers and critical success factors for the implementation of European collaboration in the field of relative effectiveness assessment (REA) of drugs.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Health Policy

Title: Health policy (Amsterdam, Netherlands)

Publisher: Elsevier BV

ISSN (Electronic): 1872-6054

ISSN (Print): 0168-8510

Publication date (Electronic): May 2015

Volume: 119

Issue: 5

Affiliations

[1 ] National Health Care Institute (Zorginstituut Nederland), PO Box 320, 110 XH Diemen, The Netherlands; University of Utrecht, PO Box 80082, 3508 TB Utrecht, The Netherlands. Electronic address: skleijnen@zinl.nl.

[2 ] ToendersdeGroot Consultants, Boomstede 281, 3608 AN Maarssen, The Netherlands.

[3 ] Agency for Quality and Accreditation in Health Care and Social Welfare (Agencija za kvalitetu i akreditaciju u zdravstvu i socijalnoj skrbi), Planinska 13, HR-10000 Zagreb, Croatia.

[4 ] National Institute for Health and Care Excellence, 10 Spring Gardens, London SW1A 2BU, England, United Kingdom.

[5 ] The Institute for Quality and Efficiency in Healthcare (Institut für Qualität und Wirtschaftlichkeit im Gesundheidswesen), Im Mediapark 8, D-50670 Köln, Germany.

[6 ] French National Authority for Health (Haute Autorité de Santé), 2, avenue du Stade de France, 93218 Saint-Denis La Plaine Cedex, France.

[7 ] Association of Austrian Social Insurance Institutions (Hauptverband der Österreichischen Sozialversicherungsträger), Postfach 600, 1031 Vienna, Austria; University of Vienna, Brünner Straße 72, 1210 Vienna, Austria.

[8 ] Italian Medicines Agency (Agenzia Italiana del Farmaco), Via del Tritone, 181, 00187 Rome, Italy.

[9 ] National Health Care Institute (Zorginstituut Nederland), PO Box 320, 110 XH Diemen, The Netherlands.

[10 ] Agency for Health Technology Assessment and Tariff System in Poland (Agencja Oceny Technologii Medycznych i Taryfikacji), ul. I. Krasickiego 26, 02-611 Warsaw, Poland.

[11 ] Danish Health and Medicines Authority (Sundhedsstyrelsen), Axel Heides Gade 1, 2300 Copenhagen S, Denmark; University of Southern Denmark, Campusvej 55, DK 5230 Odense M, Denmark.

[12 ] National Health Care Institute (Zorginstituut Nederland), PO Box 320, 110 XH Diemen, The Netherlands; University of Utrecht, PO Box 80082, 3508 TB Utrecht, The Netherlands.

Article

Publisher Item ID: S0168-8510(15)00034-2

DOI: 10.1016/j.healthpol.2015.01.018

PubMed ID: 25703539

SO-VID: 518a6b42-eece-4980-90bf-425a7b0efb07

History

Keywords: European collaboration,Health technology assessment,Pharmaceuticals,Reimbursement,Relative effectiveness,Relative effectiveness assessment

Data availability:

Keywords: European collaboration, Health technology assessment, Pharmaceuticals, Reimbursement, Relative effectiveness, Relative effectiveness assessment

European collaboration on relative effectiveness assessments: What is needed to be successful?

Read this article at

Abstract

Related collections

Journal of European Landscapes

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Cited by 3